{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:05:16Z","timestamp":1790395516881,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.ajog.2007.04.027","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T08:33:30Z","timestamp":1186475610000},"page":"134.e1-134.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Transdermal hormonal contraception: benefits and risks"],"prefix":"10.1016","volume":"197","author":[{"given":"Ronald T.","family":"Burkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2007.04.027_bib1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.AOG.0000161958.70059.db","article-title":"Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist","volume":"105","author":"Potts","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.04.027_bib2","unstructured":"Gordon RD, Peterson TA. 4 Myths about transdermal drug delivery. Drug delivery technology. Last accessed: May 16, 2005. Available at: http:\/\/www.drugdeliverytech.com\/cgi-bin\/articles.cgi?idArticle=143."},{"key":"10.1016\/j.ajog.2007.04.027_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.me.39.020188.001253","article-title":"Transdermal delivery of drugs","volume":"39","author":"Brown","year":"1988","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.ajog.2007.04.027_bib4","first-page":"135","article-title":"Transdermal delivery systems","volume":"11","author":"Merkle","year":"1989","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.ajog.2007.04.027_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13697130400012239","article-title":"Transdermal hormone therapy: gels and patches","volume":"7","author":"Samisoe","year":"2004","journal-title":"Climacteric"},{"key":"10.1016\/j.ajog.2007.04.027_bib6","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0378-5122(99)00061-4","article-title":"Optimising delivery systems for HRT","volume":"33","author":"Stevenson","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2007.04.027_bib7","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0378-5122(99)00062-6","article-title":"OESCLIM\u00ae: an advanced delivery system for HRT","volume":"33","author":"Munoz","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2007.04.027_bib8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.293.17.2083","article-title":"Breaking barriers in transdermal drug delivery","volume":"293","author":"Hampton","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2007.04.027_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/mi.4.6.1","article-title":"Transdermal drug delivery: past, present, future","volume":"4","author":"Scheindlin","year":"2004","journal-title":"Mol Interv"},{"key":"10.1016\/j.ajog.2007.04.027_bib10","first-page":"230","article-title":"A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol","volume":"42","author":"Lippman","year":"1997","journal-title":"Int J Fertil"},{"key":"10.1016\/j.ajog.2007.04.027_bib11","series-title":"Product labeling","year":"2006"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2007.04.027_bib12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","article-title":"Pharmacokinetic overview of Ortho Evra\u2122\/Evra\u2122","volume":"77","author":"Abrams","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2007.04.027_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-18645","article-title":"Transdermal contraception","volume":"19","author":"Creasy","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2007.04.027_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","article-title":"Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol","volume":"151","author":"Goebelsmann","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.04.027_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 \u03bcg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2007.04.027_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.04.027_bib17","series-title":"Thromboembolism in pregnancy: ACOG Practice Bulletin no.: 19","year":"2000"},{"key":"10.1016\/j.ajog.2007.04.027_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2007.04.027_bib19","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2007.04.027_bib20","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\u2122\/Evra\u2122 transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2007.04.027_bib21","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0015-0282(01)03264-2","article-title":"A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\u2122\/Evra \u2122)","volume":"77","author":"Sibai","year":"2002","journal-title":"Fertil Steril"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2007.04.027_bib22","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0015-0282(01)03262-9","article-title":"Integrated summary of Ortho Evra\u2122\/Evra \u2122 contraceptive patch adhesion in varied climates and conditions","volume":"77","author":"Zacur","year":"2002","journal-title":"Fertil Steril"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2007.04.027_bib23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\u2122\/Evra \u2122) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2007.04.027_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra\u00ae) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2007.04.027_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(02)00351-7","article-title":"Quick start: novel oral contraceptive initiation method","volume":"66","author":"Westhoff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2007.04.027_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.contraception.2005.05.009","article-title":"Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods","volume":"72","author":"Murthy","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2007.04.027_bib27","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937807005480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937807005480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:22:08Z","timestamp":1757586128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937807005480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0002937807005480"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2007.04.027","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal hormonal contraception: benefits and risks","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2007.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}